Item 2.02 Results of Operations and Financial Condition.

On August 6, 2020, Twist Bioscience Corporation (the "Company") issued a press release announcing its financial results for the third quarter ended June 30, 2020. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



Exhibit
  No.                                    Description

99.1          Press release dated August 6, 2020 titled "Twist Bioscience Reports
            Third Quarter Fiscal 2020 Financial Results."

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses